Many long COVID patients adjust to slim recovery odds as world moves on
The best window for recovery is in the first six months after getting COVID-19, with better odds for people whose initial ...
manilatimes15h
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...